Contraindications to intentional weight loss;Kontraindikationen zur gewichtsreduktion

Therapeutische Umschau

Volumn 57, Issue 8, 2000, Pages 537-541

  Heini, A ^a  

^a FMH Innere Medizin   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CONTRAINDICATION; ECONOMICS; FITNESS; GERMANY; HEALTH CARE COST; HUMAN; LOW CALORY DIET; OBESITY; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION;

DIET, REDUCING; GERMANY; HEALTH CARE COSTS; HUMANS; OBESITY; PHYSICAL FITNESS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0034242356     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.8.537     Document Type: Article

References (25)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-9.
2. Manson JE, Willett WC, Stampfer MJ, Colditz GA, et al. Body weight and mortality among women. NEJM 1995; 333: 677-85.
3. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-6.
4. Huang Z, Willet WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998; 128: 81-8.
5. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995; 141: 1117-27.
6. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995; 141: 1128-41.
7. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16: 397-415.
8. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993; 119: 1029-35.
9. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992; 55: 652-58.
10. Weinsier RL, Ullmann DO. Gallstone formation and weight loss. Obesity Res 1993; 1: 51-6.
11. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995; 98: 115-7.
12. Jensen LB, Quaade F, Sorensen OH. Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 1994; 9: 459-63.
13. Salamone LM, Cauley JA, Black DM, et al. Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomised trial. Am J Clin Nutr 1999; 70: 97-103.
14. National Task Force on the Prevention and Treatment of Obesity. Weight cycling. JAMA 1994; 272: 1196-202.
15. Yanovski SZ, Sebring NG. Recorded food intake of obese women with binge eating disorder before and after weight loss. Int J Eat Disord 1994; 15: 135-50.
16. Venditti EM, Wing RR, Jakicic JM, Butler GA, Marcus MD. Weight cycling, psychological health, and binge eating in obese women. J Consult Clin Psychol 1996; 64: 400-5.
17. Telch CF, Agras WS. The effects of a very-low-calorie diet on binge eating. Behav Ther 1993; 24: 177-93.
18. Sjostrom L, Rissanen A, Andersen T, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167-72.
19. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999; 281: 235-42.
20. Pierce NS, Stubbs TA, Macdonald IA, Tattersall RB. The effect of sibutramine and weight reduction on insulin sensitivity in obese type 2 diabetics. Int J Obes 1998; 22 (Suppl 3): 669.
21. Klein S. The war against obesity: attacking a new front. Am J Clin Nutr 1999; 69: 1061-3.
22. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 403-7.
23. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999; 282: 1547-53.
24. Lyons P, Miller WC. Effective health promotion and clinical care for large people. Med Sei Sports Exerc 1999; 31: 1141-6.
25. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertenion 1999; 33 (part II): 537-41.